RANI THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 29 Jan 2025)
What this means for you
Registered since 30 Oct 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86600602
- Registration number
- 5595986
- Mark type
- Stylized text
- Filed
- 17 Apr 2015
- Published for opposition
- 05 Jan 2016
- Registered
- 30 Oct 2018
- Attorney of record
- Mary Margaret O'Donnell
Goods and services
- Class 005 — Pharmaceuticals: DRUG DELIVERY AGENTS IN THE FORM OF SWALLOWABLE DEVICES IN THE NATURE OF GELATIN CAPSULES AND MECHANISMS IN THE NATURE OF PILLS AND CAPSULES THAT FACILITATE THE DELIVERY OF PHARMACEUTICALS IN THE NATURE OF PROTEINS, ANTIBODIES, PEPTIDES, SMALL MOLECULES OR OTHER THERAPEUTIC OR DIAGNOSTIC COMPOUNDS INTO THE WALL OF AN INTESTINAL TRACK OF A HUMAN OR OTHER MAMMAL
Owner
- Rani Therapeutics, LLC, San Jose, CA, US
- Rani Therapeutics, LLC, San Jose, CA, US
- Rani Therapeutics, LLC, San Jose, CA, US
Prosecution history
- 29 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 29 Jan 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Sept 2024 — TEAS SECTION 8 & 15 RECEIVED
- 30 Oct 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 30 Oct 2018 — REGISTERED-PRINCIPAL REGISTER
- 26 Sept 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Sept 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 31 Aug 2018 — USE AMENDMENT FILED
- 24 Sept 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 31 Aug 2018 — TEAS STATEMENT OF USE RECEIVED
- 22 Feb 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Feb 2018 — SOU EXTENSION 4 GRANTED
- 20 Feb 2018 — SOU EXTENSION 4 FILED